Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan 80/HCTZ 25 vs 80/12.5 in Uncontrolled Hypertension
NCT00239369Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2005
- Primary completion
- Aug 2006
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 3 trial of telmisartan, hydrochlorothiazide in hypertension (HTN), sponsored by Boehringer Ingelheim. Started Oct 2005; status: completed.
02
Drugs
telmisartanhydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00239369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00239369.